NMC finally decides it will take up patients’ appeals against state council rulings | India News – The Times of India

NMC finally decides it will take up patients’ appeals against state council rulings | India News – The Times of India

In a victory for patients’ rights, the National Medical Commission has decided that it will take up appeals of patients in cases against doctors. For almost five years, since the NMC was constituted in September 2020, it has been rejecting patients’ appeals stating that only doctors have the right to appeal against decisions of state…

Read More
Not taking chances, government hospital GMCH in Rajouri delays discharge of 8 Badhaal patients | India News – The Times of India

Not taking chances, government hospital GMCH in Rajouri delays discharge of 8 Badhaal patients | India News – The Times of India

JAMMU: Not taking any chances with the health of eight patients from Badhaal village in J&K’s Rajouri district who recently recovered from the “mystery illness” after being treated with atropine medication, Rajouri Government Medical College and Hospital authorities Tuesday delayed their discharge until the final report on the toxins they had ingested was made available…

Read More
Paxlovid Improved Long Covid Symptoms in Some Patients, Researchers Report

Paxlovid Improved Long Covid Symptoms in Some Patients, Researchers Report

Can Paxlovid treat long Covid? A new report suggests it might help some patients, but which patients might benefit remains unclear. The report, published Monday in the journal Communications Medicine, describes the cases of 13 long Covid patients who took extended courses of the antiviral drug. Results were decidedly mixed: Nine patients reported some improvement,…

Read More
J&J denied extension of patent on TB drug, to benefit patients | India News – Times of India

J&J denied extension of patent on TB drug, to benefit patients | India News – Times of India

New Delhi: In a move that will benefit tuberculosis patients, Indian Patent Office (IPO) has denied the US giant Johnson & Johnson’s request to extend its patent on the life-saving TB drug Bedaquiline. This ruling potentially facilitates the entry of affordable versions of the long-acting injectable Bedaquiline over the next few years, improving access for…

Read More